John Rice, Lisa Cervantes, Michael R. Lucey – 23 July 2012 – Watch the interview with the authors

John Rice, Lisa Cervantes, Michael R. Lucey – 23 July 2012 – Watch the interview with the authors

Sanjeev Arora, Karla Thornton, Andrea Bradford – 23 July 2012 – Watch a video presentation of this article

Diana L. Sylvestre – 23 July 2012 – Watch an interview with the author

Andres F. Carrion, Paul Martin – 23 July 2012 – Watch the interview with the authors

Ho‐Geol Ryu, Chul‐Woo Jung, Hyung‐Chul Lee, Youn‐Joung Cho – 23 July 2012 – Acute hypotension after reperfusion of the liver graft occurs frequently during liver transplantation. A randomized, prospective trial was performed to test the effects of epinephrine and phenylephrine pretreatments for attenuating postreperfusion syndrome (PRS). Ninety‐three adult liver recipients were randomly allocated to receive an intravenous bolus of 10 μg of epinephrine, 100 μg of phenylephrine, or normal saline (the control group) at the time of graft reperfusion.

Michael J. Englesbe – 23 July 2012

Wolfram Goessling – 23 July 2012

Gregory T. Everson, Norah A. Terrault, Anna S. Lok, Del R. Rodrigo, Robert S. Brown, Sammy Saab, Mitchell L. Shiffman, Abdullah M.S. Al‐Osaimi, Laura M. Kulik, Brenda W. Gillespie, James E. Everhart, and the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study – 23 July 2012 – Hepatitis C virus (HCV) infection recurs in liver recipients who are viremic at transplantation. We conducted a randomized, controlled trial to test the efficacy and safety of pretransplant pegylated interferon alpha‐2b plus ribavirin (Peg‐IFN‐α2b/RBV) for prevention of post‐transplant HCV recurrence.

Douglas Mogul, Kathleen B. Schwarz – 23 July 2012 – Watch an interview with Dr. Schwarz